European health tech and AI companies maintained a strong appeal among global venture capital investors, raising $13.9 billion in Q1 2025, according to Dealroom data. This represents a 2% year-over-year increase, matching investment levels from the previous quarter. Healthtech was among the top-funded verticals, with digital health capturing a substantial chunk of capital flows in Europe.
This momentum is especially meaningful for mental health tech, a niche that has long been undercapitalised relative to broader digital health. As we mark World Mental Health Day today, European startups in this space are stepping into view with innovative solutions that address the urgent necessary for accessible mental health support.
Below are 10 mental health startups across Europe to watch in 2025, each contributing to the vision of mental health as a universal right.
Unmind (UK)
Founder/s: Ry Morgan, Nick Tong, Nick Taylor, Steve Peralta
Founded year: 2016
Total funding: $96.5M
Workplace mental health platform Unmind combines various supports, including therapy, coaching, leadership training, and consulting, with AI-powered tools to assist organisations support employee mental wellbeing. One of its signature offerings is “Nova”, an AI agent designed to offer instant personalised mental health support to employees, with the idea that this complements human care rather than replacing it.
In July 2025, Unmind raised €30.6 million in a Series C round. The round was led by TELUS Global Ventures, with existing investors including Project A, Felix Capital, and Sapphire Ventures participating. The aim with this funding is to scale globally with particular attention to the U.S., enhance reach, and further develop AI tools like Nova.
Neurocare (Germany)
Founder/s: Thomas Mechtersheimer, Kevin Reeder
Founded year: 2015
Total funding: $38.2M
Neurocare is focapplyd on mental health care in Germany, offering remote therapy and digital mental health tools. It typically provides psychological support, counselling, and follow-up care via digital means, integrating clinical expertise with technology to reach people who might not have straightforward access to in-person therapy.
In February this year, the company received a €19 million investment from Impact Expansion and existing shareholder TVM Capital Healthcare. This funding will support Neurocare’s global growth and development of its mental health technologies and services.
HelloBetter (Germany)
Founder/s: Dr. David Ebert, Dr. Hanne Horvath, Dr. Elena Heber
Founded year: 2015
Total funding: $37.4M
Digital mental health startup HelloBetter provides evidence-based online mental health interventions. Their offerings tconclude to be digital therapeutic programmes for issues such as depression, anxiety, insomnia, and stress, typically structured courses backed by clinical research. The goal is to provide scalable, accessible mental health support via digital modalities, often self-guided or with minimal therapist involvement.
Earlier this year, the company created a €6 million payment. The funding round was led by Mutuelles Impact, managed by XAnge, with participation from MMV, HealthCap, Expon, and DVH Ventures. With this funding, the company plans to enter the French market in 2025, leveraging partnerships with Mutuelles Impact and seeking regulatory approval for nationwide reimbursement.
Healios (UK)
Founder/s: Richard Andrews
Founded year: 2013
Total funding: $31.4M
UK-based provider of virtual mental health services Healios is particularly for young people. It delivers remote psychotherapy, psychiatric assessments, and digital interventions, often working in collaboration with the NHS or other health providers. Its model includes both direct-to-consumer offerings and partnerships with public health systems to expand access to children’s and adolescent mental health care.
Back in 2022, Healios raised £14 million to expand its online mental health, autism, and ADHD services for children and young people across the US and UK. The round saw participation from AlbionVC, InHealth Ventures, and Autism Impact Fund. Funds will fuel Meliora Health’s US expansion and enhance assessment, intervention, and machine learning-driven clinical research.
Mindler (Sweden)
Founder/s: Rickard Lagerqvist, Rickard Färdig, Johannes Hatem
Founded year: 2018
Total funding: $25.2M
Swedish mental health platform Mindler combines digital access with licensed psychologists. Through teleconsultations, self-assist content, and measurement tools, the platform offers both reactive (therapy sessions) and preventive (self-guided modules) support. The focus is on seamless applyr experience, minimal wait times, and integration with employer or health plans across Nordic markets.
In August, Mindler acquired UK-based Ieso Digital Health to strengthen its position in online therapy. The acquisition gives Mindler access to National Health Service contracts in England and Scotland.
Moka.care (France)
Founder/s: Pierre-Etienne Bidon, Guillaume d’Ayguesvives
Founded year: 2019
Total funding: $19.3M
French startup Moka.care positions itself as a mental well-being platform for women, offering tools, coaching, and peer communities focapplying on women’s mental health, life transitions, and holistic care. Its services combine digital modules, live coaching, content, and community support, a model blconcludeing prevention, coaching, and therapeutic adjunct.
Moka.care has raised $16 million in a Series A round led by Left Lane Capital, with Singular rejoining as an existing investor. Sporting legconcludes Blaise Matuidi and Antoine Griezmann, both French footballers, and Antoine Dupont, captain of the French rugby team, also participated in the round.
Serenis Health (Italy)
Founder/s: Daniele Francescon, Silvia Wang
Founded year: 2021
Total funding: $19.2m
Italy’s Serenis Health offers a digital mental health and neuropsychology platform focapplyd on diagnostics, therapy, and monitoring for emotional and cognitive disorders. It combines self-assessment tools, teletherapy, and clinician dashboards, with a special emphasis on neurocognitive health across the lifespan, such as aging, cognitive decline, and stress.
Recently, Serenis Health snapped $12 million in funding in a round led by Angelini Ventures and CDP Venture Capital. The company intconcludes to apply the funds to expand operations and its development efforts.
Oliva Health (UK)
Founder/s: Javier Suarez, Sancar Sahin
Founded year: 2020
Total funding: $14M
UK platform Oliva Health specialises in integrated mental health & medicine subscription care. It blconcludes clinical therapy, psychiaattempt, and coaching under one roof for chronic mental health conditions. The model aims to provide continuity of care (therapy, medication and coaching) in a digital-first, patient-centric format.
Back in 2023, Oliva Health secured €5 million in funding led by Molten Ventures, alongside participation from existing investor Stride VC, new backer Alumni Ventures and angel investor Kieran Flanagan, CMO at Zapier. It will be applyd to expand its network of therapists and launch into new markets.
Elkedonia (France)
Founder/s: Melanie Rouillier, Delphine Charvin
Founded year: 2025
Total funding: $12.4M
Elkedonia is a very new startup founded this year in France. It is focapplyd on mental health support. It is pioneering a novel neuroplastogen approach to develop therapeutic agents to treat depression and other neuropsychiatric conditions. Elkedonia is introducing a first-in-class antidepressant approach that leverages precision medicine.
The company secured €11.25 million in seed funding co-led by Kurma Partners, WE Life Sciences, and the French Tech Seed fund managed on behalf of the French government by Bpifrance as part of France 2030, with participation from Argobio, Angelini Ventures, CARMA Fund, Capital Grand Est and Sambrinvest.
Clerkenwell Health (UK)
Founder/s: Dr Henry Fisher, Tom McDonald, Sam Lewis, George McBride
Founded year: 2020
Total funding: $4.4M
UK-based Clerkenwell Health is a startup operating in the mental health sector, specifically focapplying on the development and delivery of innovative mental health treatments and technologies. The company’s primary function is to facilitate clinical research and care delivery, acting as a conduit between groundbreaking mental health solutions and the patients who necessary them most.
Clerkenwell Health has raised £2.1 million in seed funding, which will be applyd to receive the London-based startup fully operational. Investors include Lionheart Ventures, Convergence Partners and Exceptional Ventures.
Leave a Reply